Skip to main content
UK clinical trials - updated daily from ClinicalTrials.gov
TrialConnect
← Back to Search
Looking for participantsN/A

Electroporation for Cancer Treatment Real World Registry

Sponsor: Mirai Medical

NCT ID: NCT04929912

View on ClinicalTrials.gov ↗

At a glance

What the study gets you
Health checks and monitoring — no treatment given
Type of study
Observational (no treatment given)
Time in hospital
In-person visits at study sites — visit count not specified by the sponsor
Drug or intervention
Not specified by the sponsor
How long the study runs
Study runs about 180 months (dates as stated)
About the drug or intervention
Not specified by the sponsor
Patient visit burden
Not specified by the sponsor
Type of study
Observing health over time
Ages
Not specified
Who
All
Number of participants
1,000
Started
2021-06-24
Last checked
2025-01

Plain English Summary

What is this study?

  • • Testing a new treatment for skin cancer
  • • Clinical study - 1,000 participants
  • • This registry aims to assess real-world long-term disease outcomes for patients treated using reversible electroporation and a chemotherapeutic or calcium; in particular tumour response rates and recurrence rates

Who can take part?

  • • Adults
  • • Diagnosed with skin cancer

Where?

  • • London - Royal London Hospital

This is a simplified summary. Always discuss with your doctor before making any decisions.

About This Trial

This registry aims to assess real-world long-term disease outcomes for patients treated using reversible electroporation and a chemotherapeutic or calcium; in particular tumour response rates and recurrence rates. The study also aims to characterise side effects and the occurrence of Adverse Events and their relationship to the treatment.

Skin CancerGastrointestinal Cancer

How this trial compares with your answers

Answer 2 more questions to improve match

What we know so far

Condition· Matched your search
Age· Tell us your age for better matching
Gender· Tell us your sex for better matching

Still need:

  • • Tell us your age for better matching
  • • Tell us your sex for better matching

Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.

Eligibility at a Glance

Key info

  • Age: Not specified
  • Who can join: All genders

What the study is looking for

  • ✓Any patient who has been treated using Calcium Electroporation
  • ✓Any patient who has been treated using Electrochemotherapy
  • ✓Patients must be mentally capable of understanding the information given
  • ✓Patients must give written agreement to take part.
See the full criteria
Inclusion Criteria: * Any patient who has been treated using Calcium Electroporation * Any patient who has been treated using Electrochemotherapy * Patients must be mentally capable of understanding the information given * Patients must give written informed consent. Exclusion Criteria: * None

Where Is This Study? (1 UK site)

Royal London Hospital

London E1 1FR, United Kingdom

Recruiting
Site contact (verified)
Greme MoirPrincipal Investigator

How to Get in Touch

SEAN H KINSELLA

Sponsor contact

CONTACT

+353 91 442 498 sean@mirai-medical.com

Declan Soden

Sponsor contact

CONTACT

declan@mirai-medical.com
Data sourced from ClinicalTrials.gov · Last verified: 2025-01